Subtype
Cervical Carcinoma
CI-CAN-00004782Explore in graph →
170 active trials1 approved drugs8 evidence items
- NCIt
- C9039
- DOID
- 2893
- Other
- 2 more codes
Loading cancer entity…
Subtype
CI-CAN-00004782Explore in graph →
Clinical trials
504 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (54)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00595725 | Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma | completed | N/A | 151 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT01427101 | Results of CRS and Debulking in PMP Patients | unknown | — | — | Uppsala UniversityOTHER | 0 | Sep 1, 2011 | clinicaltrials |
| NCT00423254 |
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. |
| completed |
| Phase 1 |
| 12 |
| Mannkind CorporationINDUSTRY |
| 1 |
| Aug 3, 2010 |
| clinicaltrials |
| NCT00673192 | Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | May 7, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Sep 8, 2011source: clinicaltrials